|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
Q1 FY2019
As of Mar 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q3 FY2018
As of Sep 30, 2018
|
Q2 FY2018
As of Jun 30, 2018
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Current assets: | ||||||||||||
| Cash and cash equivalents | ||||||||||||
| Marketable securities | ||||||||||||
| Prepaid expenses and other current assets | ||||||||||||
| Total current assets | ||||||||||||
| Property and equipment, net | ||||||||||||
| Deferred offering costs | ||||||||||||
| Restricted cash | ||||||||||||
| Operating lease, right-of-use assets | ||||||||||||
| Other assets | ||||||||||||
| Total assets | ||||||||||||
| Liabilities and Stockholders' Equity | ||||||||||||
| Current liabilities: | ||||||||||||
| Accounts payable | ||||||||||||
| Accrued expenses and other current liabilities | ||||||||||||
| Current portion of long-term debt, net of discount | ||||||||||||
| Current portion of lease liabilities - operating lease | ||||||||||||
| Total current liabilities | ||||||||||||
| Preferred stock warrant liability | ||||||||||||
| Long-term debt, net of current portion and discount | ||||||||||||
| Operating lease liabilities, net of current portion | ||||||||||||
| Deferred rent, net of current portion | ||||||||||||
| Other long-term liabilities | ||||||||||||
| Total liabilities | ||||||||||||
| Convertible preferred stock (Series A, B, D, E, E-1 and F), $0.001 par value; no shares and 119,391,806 shares authorized at December 31, 2018 and 2017, respectively; no shares and 118,867,177 shares issued and outstanding at December 31, 2018 and 2017, respectively; aggregate liquidation preference of $0 and $178,762 at December 31, 2018 and 2017, respectively | ||||||||||||
| Stockholders' equity: | ||||||||||||
| Common stock, $0.0001 par value; 200,000,000 shares authorized at March 31, 2021 and December 31, 2020; 47,913,147 and 47,744,486 shares issued and outstanding at March 31, 2021 and December 31, 2020, respectively | ||||||||||||
| Additional paid-in capital | ||||||||||||
| Accumulated other comprehensive gain (loss) | ||||||||||||
| Accumulated deficit | ||||||||||||
| Total stockholders' equity | ||||||||||||
| Total liabilities and stockholders' equity |
Loading...
